These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5596770)

  • 1. [Resistance to antivitamins K in man].
    Soulier JP; Blatrix C; Tillement JP
    Coeur Med Interne; 1967 Jan; 6(1):37-46. PubMed ID: 5596770
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypersensitivity and resistance to antivitamins K].
    Keréveur A; Trossaert M; Horellou MH; Conard J; Dupeyron JP; Samama M
    Arch Mal Coeur Vaiss; 1995 Apr; 88(4):487-95. PubMed ID: 7646267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anticoagulants. Antivitamins K: principles and rules of use, posology].
    Mismetti P; Decousus H
    Rev Prat; 1995 Apr; 45(8):1014-7. PubMed ID: 7761767
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ambulatory therapy with antivitamins K].
    Caviezel O
    Schweiz Rundsch Med Prax; 1971 Jan; 60(3):80-2. PubMed ID: 5549861
    [No Abstract]   [Full Text] [Related]  

  • 6. [Does a metabolic interaction exist between viloxazine and antivitamins K?].
    Chiffoleau A; Delavaud P; Spreux A; Fialip J; Kergueris MF; Chichmanian RM; Lavarenne J; Bourin M; Larousse C
    Therapie; 1993; 48(5):492-3. PubMed ID: 8146838
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug interactions with antivitamins K].
    Chrétien P; Boismare F
    LARC Med; 1983 Nov; 3(9):625-32. PubMed ID: 6656516
    [No Abstract]   [Full Text] [Related]  

  • 8. [Recommendations of the Hemostasis and Thrombosis Study Group. Toward better monitoring of anticoagulant treatment with antivitamins K].
    Ann Med Interne (Paris); 1986; 137(6):530-1. PubMed ID: 3813290
    [No Abstract]   [Full Text] [Related]  

  • 9. [Toward better monitoring of anticoagulant treatment with antivitamins K. Recommendations of the Hemostasis and Thrombosis Study Group].
    Ann Cardiol Angeiol (Paris); 1986 Oct; 35(8):499-500. PubMed ID: 3813457
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anticoagulant therapy with antivitamins K].
    Bokarev IN; Kabaeva EV
    Klin Med (Mosk); 1984 Jan; 62(1):18-24. PubMed ID: 6708415
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vitamin K antagonists].
    Lefrère JJ; Samama M
    Soins; 1987 Dec; (507):45-9. PubMed ID: 3438754
    [No Abstract]   [Full Text] [Related]  

  • 12. [Oral antivitamins K].
    Agence Française De Sécurité Sanitaire Des Produits De Santé
    J Mal Vasc; 2001 Jun; 26(3):196-205. PubMed ID: 11431625
    [No Abstract]   [Full Text] [Related]  

  • 13. Warfarin resistance and enteral tube feeding: a vitamin K-independent interaction.
    Dickerson RN
    Nutrition; 2008 Oct; 24(10):1048-52. PubMed ID: 18602249
    [No Abstract]   [Full Text] [Related]  

  • 14. Antivitamins for Medicinal Applications.
    Zelder F; Sonnay M; Prieto L
    Chembiochem; 2015 Jun; 16(9):1264-78. PubMed ID: 26013037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antivitamins K, one must return to their good usage].
    Manus JM
    Rev Infirm; 2002 Mar; (79):38-9. PubMed ID: 11979676
    [No Abstract]   [Full Text] [Related]  

  • 16. [Control of long-term therapy with antivitamins K].
    Mascart P; Cloetens W
    Angeiologie; 1967; 19(5):45-8. PubMed ID: 5621972
    [No Abstract]   [Full Text] [Related]  

  • 17. [Biologic control of long-term anti-coagulating therapy with antivitamins K].
    Samama M; Casubolo L
    Angeiologie; 1967; 19(5):37-43. PubMed ID: 5621971
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vitamin K antagonists].
    D'Agostino F; D'Agostino M; Cambiè G; Cuccia A
    Riv Emoter Immunoematol; 1983; 30(1):1-31. PubMed ID: 6635478
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimal reversal of vitamin K antagonists.
    Schulman S
    Thromb Res; 2007; 119(1):15-6. PubMed ID: 16310838
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biological study of a new antivitamin K anticoagulant 3-(alpha-acetonylbenzyl) 4-hydroxycoumarin dimethylaminoethanol. (100 cases)].
    Migne J; Monteil R; Pessereau G; Pernod J; Siau J
    Therapie; 1968; 23(3):553-66. PubMed ID: 5740621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.